首页> 外文会议>5th International Photodynamic Association Biennial Meeting >Preliminary report of clinical application of hematoporphyrin monomethylether in photodynamic therapy for alimentary cancers,
【24h】

Preliminary report of clinical application of hematoporphyrin monomethylether in photodynamic therapy for alimentary cancers,

机译:血卟啉单甲醚在光动力疗法治疗消化道癌症中的临床应用的初步报告,

获取原文

摘要

Abstract: A new sensitizer, hematoporphyrin monomethyl ether (HMME), purified by the Second Military Medical University was used with a gold vapor laser for PDT in 8 cases of alimentary cancers. The results showed that 2 cases of early stage gastric cancer and 1 case of rectal polyps with malignancy revealed CR, SR was obtained in 1 case of esophageal cancer and 4 others were MR. No sunburn occurred within the 8 patients who received 12 doses of HMME at 5 mg/kg 2 - 3 hours prior to laser treatment and who were kept away from sun light only 6 hours. Hematoporphyrin monomethyl ether is an effective single compound and safer for PDT. !1
机译:摘要:第二军医大学纯化的新敏化剂,血液卟啉单甲基醚(HMME),用于8例消化癌的PDT金蒸气激光器。结果表明,2例早期胃癌和1例直肠息肉,恶性肿瘤揭示了CR,SR在1例食管癌中获得,另外4例是MR。在激光治疗前的5毫克/千克2 - 3小时内接受12剂HMME的8名患者中没有发生晒伤,并且只有6小时,谁远离阳光。血红蛋白单甲醚是一种有效的单一化合物,并加强PDT。 !1

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号